Key principles and clinical applications of "next-generation" DNA sequencing

• Published in: Cancer prevention research (Philadelphia, Pa.) Vol. 5; no. 7; pp. 887 - 900
• Main Authors: Rizzo, Jason M, Buck, Michael J
• Format: Journal Article
• Language: English
• Published: United States 01.07.2012
• Subjects: Genome, Human; Genomics; Humans; Sequence Analysis, DNA; Translational Medical Research
• ISSN: 1940-6207; 1940-6215
• DOI: 10.1158/1940-6207.CAPR-11-0432

Demand for fast, inexpensive, and accurate DNA sequencing data has led to the birth and dominance of a new generation of sequencing technologies. So-called "next-generation" sequencing technologies enable rapid generation of data by sequencing massive amounts of DNA in parallel using diverse methodologies which overcome the limitations of Sanger sequencing methods used to sequence the first human genome. Despite opening new frontiers of genomics research, the fundamental shift away from the Sanger sequencing that next-generation technologies has created has also left many unaware of the capabilities and applications of these new technologies, especially those in the clinical realm. Moreover, the brisk evolution of sequencing technologies has flooded the market with commercially available sequencing platforms, whose unique chemistries and diverse applications stand as another obstacle restricting the potential of next-generation sequencing. This review serves to provide a primer on next-generation sequencing technologies for clinical researchers and physician scientists. We provide an overview of the capabilities and clinical applications of DNA sequencing technologies to raise awareness among researchers about the power of these novel genomic tools. In addition, we discuss that key sequencing principles provide a comparison between existing and near-term technologies and outline key advantages and disadvantages between different sequencing platforms to help researchers choose an appropriate platform for their research interests.